Reimbursed Care Access in Guernsey

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Local reporting and the Bailiwick Misuse of Drugs framework treat classical psychedelics as controlled (importation, possession and supply are criminal offences). # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. MDMA possession and supply are prosecuted in Guernsey under the Misuse of Drugs regime; reported local prosecutions for MDMA possession reflect active enforcement. # #.

Esketamine (SPRAVATO) is a licensed medicine in multiple jurisdictions but there is no public evidence of routine, on‑island NHS‑style reimbursement or an established publicly‑funded treatment centre in Guernsey. SPRAVATO in other jurisdictions is subject to strict risk‑mitigation programmes and clinic certification (REMS‑style requirements) and is typically administered only in certified healthcare settings. Guernsey regulates prescription‑only medicines and has updated local medicines regulation powers (Committee for Health & Social Care) which govern whether nationally licensed medicines may be supplied locally; this creates a pathway for prescription use but does not imply automatic public reimbursement. In practice, access to esketamine for psychiatric indications in the Bailiwick would likely be arranged through private clinics, off‑island referral, or a locally authorised prescription rather than funded as routine care by the States Health Service. Key references: SPRAVATO regulatory/REMS requirements and international availability; Guernsey Medicines (Human and Veterinary) Law amendments showing local prescription regulation. # #.

Ketamine is legally used in Guernsey for established medical indications (e.g., anaesthesia) and can be prescribed/used in licensed health settings; it has also been discussed locally as a controlled drug in regulatory updates. For psychiatric indications (e.g., off‑label use in treatment‑resistant depression), access would be via clinicians operating within the Bailiwick medicines framework or via private clinics and off‑island referral — there is no public evidence of island‑wide reimbursement for repeated ketamine‑infusion psychiatric programmes. The local Misuse of Drugs advisory work and news coverage indicate ketamine has been (re)classified and is monitored locally, meaning clinical use requires appropriate licensing/clinical governance. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. DMT (and LSD) are treated in many Commonwealth jurisdictions as Schedule I/controlled drugs except when a licence is granted for research; Guernsey’s Misuse of Drugs framework enforces importation and possession prohibitions. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. There is no local pathway for routine medical use in Guernsey. #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. There is no recognised medical or reimbursed provision for ibogaine in Guernsey. #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Components of ayahuasca (DMT-containing brews) fall under controlled‑substance prohibitions; importation/possession is a criminal offence unless specifically licensed for research. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Mescaline and peyote‑type materials are treated as controlled; there is no authorised therapeutic pathway in Guernsey. # #.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. '2C‑' family phenethylamines are monitored and controlled under local legislation and importation/supply is illegal absent a research licence. # #.